Voyager Therapeutics (VYGR) Free Cash Flow (QoQ) (2015 - 2026)
Voyager Therapeutics (VYGR) Free Cash Flow (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - |
| 10 | Voyager Therapeutics | 193.96 Mn | 52.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.41% |
| Dec 31, 2025 | 8.11% |
| Sep 30, 2025 | 9.05% |
| Jun 30, 2025 | 10.86% |
| Mar 31, 2025 | -162.55% |
| Dec 31, 2024 | 47.98% |
| Sep 30, 2024 | 18.59% |
| Jun 30, 2024 | -159.02% |
| Mar 31, 2024 | 339.66% |
| Dec 31, 2023 | -4.32% |
| Sep 30, 2023 | -6,116.93% |
| Jun 30, 2023 | -100.31% |
| Mar 31, 2023 | 1,033.87% |
| Dec 31, 2022 | 25.35% |
| Sep 30, 2022 | 3.91% |
| Jun 30, 2022 | -153.72% |
| Mar 31, 2022 | 209.60% |
| Dec 31, 2021 | 155.13% |
| Sep 30, 2021 | 12.67% |
| Jun 30, 2021 | -5.88% |